Do CD4+ T cell functional responses to Epstein-Barr virus provide protective immunity against CNS lymphoma in AIDS?
Jacobson
Mark A
MA
Positive Health Program, University of California San Francisco, San Francisco General Hospital, San Francisco, California, United States of America. mjacobson@php.ucsf.edu
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology* / Q000821:virology*; D016022:Case-Control Studies; D016543:Central Nervous System Neoplasms / Q000150:complications* / Q000517:prevention & control / Q000821:virology*; D002908:Chronic Disease; D015658:HIV Infections / Q000150:complications*; D006680:HLA Antigens / Q000378:metabolism; D006239:Haplotypes; D004854:Herpesvirus 4, Human / Q000378:metabolism; D006801:Humans; D008223:Lymphoma / Q000150:complications* / Q000517:prevention & control / Q000821:virology*; D011446:Prospective Studies
D006680:HLA Antigens